Health and Human Services Secretary Alex Azar today named as his senior advisor for drug pricing reform John O’Brien, a pharmacist who previously served as deputy assistant secretary for health policy and an advisor on health reform and drug pricing. He replaces Daniel Best, who died last month. “John O’Brien has already been an integral leader in HHS’s efforts to bring down the high price of prescription drugs,” Azar said. “As a senior advisor, he will carry forward the legacy of our departed colleague Dan Best and build on the substantial progress that has already been made.” Before joining HHS, O’Brien was vice president of public policy for CareFirst BlueCross BlueShield.

Related News Articles

Headline
Food and Drug Administration Commissioner Scott Gottlieb, M.D., announced that he will step down in about a month.
Headline
The Senate last night voted 86-9 to approve President Trump’s nomination of Robert Wilkie to lead the Department of Veterans Affairs permanently.
Headline
Centers for Medicare & Medicaid Services Administrator Seema Verma today announced two additions to the agency’s leadership team.
Headline
Health and Human Services Secretary Alex Azar today named Center for Medicare…
Headline
The Senate Committee on Veterans' Affairs today voted to advance President Trump’s nomination of Robert Wilkie to lead the Department of Veterans Affairs…
Headline
Attorney General Jeff Sessions yesterday named as acting administrator of the Drug Enforcement Administration Uttam Dhillon, a past director of the Office of…